This year the DIA’s Annual EuroMeeting will be held in Amsterdam where it can celebrate its 25th anniversary. The meeting has a global perspective as it attracts well over 3,000 professionals from more than 50 countries from different industries, organisations, academic research centres, regulatory agencies and health ministries.
The proposed areas for discussion for the Euromeeting 2013 cover the areas of Pharmacovigilance and Regulatory Affairs for medicinal products and medical devices, R&D and Clinical Trials. The scope of the presentations will cover the experience gathered after the implementation of the new Pharmacovigilance legislative framework, as well as from the patients’ and Health Technology Assessment (HTA) perspective. Experts and authorities in the fields will be presenting their considerations for debate.
To read more about the programme, registration and themes of the Euromeeting, please visit DIA’s website.